De novodonor-specific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

De novodonor-specific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability

Published:2017-02-16 Issue:4 Volume:30 Page:360-370
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Kauke Teresa¹²³,Oberhauser Cornelia⁴³,Lin Viviane¹⁵³,Coenen Michaela⁴³,Fischereder Michael⁶³,Dick Andrea¹³,Schoenermarck Ulf⁶³,Guba Markus²³,Andrassy Joachim²³,Werner Jens²³,Meiser Bruno⁵³,Angele Martin²³,Stangl Manfred²³,Habicht Antje⁵³

Affiliation:

1. Laboratory of Immunogenetics; University Hospital Munich; Munich Germany

2. Clinic of General, Visceral, Transplantation, Vascular and Thoracic Surgery; University Hospital Munich; Munich Germany

3. Ludwig-Maximilians-University (LMU); Munich Germany

4. Department of Medical Informatics, Biometry and Epidemiology - IBE; Chair for Public Health and Health Services Research; Munich Germany

5. Transplant Center; University Hospital Munich; Munich Germany

6. Renal Division; Department of Internal Medicine IV; University Hospital Munich; Munich Germany

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12887/fullpdf

Reference43 articles.

1. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification;Gibney;Nephrol Dial Transplant,2006

2. Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection;Ginevri;Am J Transplant,2012

3. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts;Lachmann;Transplantation,2009

4. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules;Ntokou;Transpl Int,2011

5. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant;Wiebe;Am J Transplant,2012

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-invasive biomarkers of acute rejection in pediatric kidney transplantation: New targets and strategies;Life Sciences;2024-07

2. Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept;Clinical Immunology;2024-07

3. Human Hepatocyte Transplantation: Three Decades of Clinical Experience and Future Perspective;Stem Cells Translational Medicine;2023-12-16

4. Complement-activating donor-specific anti-HLA antibodies in solid organ transplantation: systematic review, meta-analysis, and critical appraisal;Frontiers in Immunology;2023-10-02

5. The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice;Transplant International;2023-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3